Category: Announcements

New Food Allergy Report from the US National Academies

On November 30, 2016, the US National Academies of Sciences, Engineering and Medicine (Health & Medicine Division) released a major report on food allergies: Finding a Path to Safety in Food Allergy: Assessment of the Global Burden, Causes, Prevention, Management,

Dr. Bruce Mazer named interim head of RI-MUHC

AllerGen investigator Dr. Bruce Mazer has been designated Interim Executive Director and Chief Scientific Officer (CSO) of the Research Institute of the McGill University Health Centre (RI-MUHC). His appointment will be effective from October 1, 2016, until a new Executive

New federal report on food allergies and air travel in Canada

The Canadian Transportation Agency (CTA) has issued a report on its “Ministerial Inquiry into Allergies to Peanuts, Nuts and Sesame Seeds in Commercial Air Travel” (June 2016). The Inquiry looked into the issue of passenger allergies to peanuts, nuts and

AllerGen names new Associate Scientific Director

Dr. Kelly McNagny, Professor of Medical Genetics and Co-Director of the Biomedical Research Centre at The University of British Columbia, has been named Associate Scientific Director of AllerGen, effective June 1, 2016, succeeding the inaugural incumbent, Dr. Dean Befus, Professor

AllerGen partner launches new anaphylaxis training course

Food Allergy Canada—the community-based advocacy, information, education and research organization and valued AllerGen partner—has launched a new online training course for parents and caregivers entitled: “Anaphylaxis in the Community: What Parents and Others Need to Know.” Developed with Leap Learning Technologies

AllerGen Board Chair leads celebration of 40 years of Family Medicine at McGill

Dr. Howard Bergman, Chair of AllerGen’s Board of Directors, recently led celebrations to mark the 40th anniversary of the Department of Family Medicine at McGill University. “When the family medicine program started at McGill University 40 years ago, there was

New Chair appointed to AllerGen’s AETOAC Committee

AllerGen is pleased to announce the appointment of Dr. Richard Hegele as the new Chair of the Network’s Advanced Education and Training Opportunities Advisory Committee (AETOAC). Dr. Hegele is Vice-Dean, Research and Innovation at the University of Toronto where he

NCE confirms AllerGen funding to 2019

AllerGen will receive ongoing federal funding through the Networks of Centres of Excellence (NCE) program to continue its work in allergic disease research, training and innovation to 2019. “After a review by the NCE’s international expert panel on September 17,

CHILD Study video in CIHR Competition

Update: In January 2016, the CHILD Study video was awarded first place in this competition. The CHILD Study whiteboard video is one of 13 entrants in the 2015 CIHR-“IHDCYH Talks” Video Competition. For the entire month of November, 2015, the

New report on Canadian anaphylaxis and allergic reactions in the emergency department

How many Canadians visit emergency departments (ED) each year due to allergic reactions and anaphylaxis? Are the numbers growing? Which months are the most common for anaphylactic emergencies? How have prescription patterns for epinephrine auto-injectors changed over time? A new

AllerGen researchers appointed to Hydra Biosciences Advisory Board

AllerGen research leader Dr. Paul O’Byrne has been appointed to the newly created Pulmonary Medical Advisory Board of Hydra Biosciences, a Massachusetts-based biopharmaceutical company that develops drugs to treat pain, inflammation, renal disease, anxiety and pulmonary disease. Dr. O’Byrne, a

AllerGen team measures air quality for PanAm Games

In partnership with AllerGen, for the past four years Dr. Greg Evans and his research team at the University of Toronto have been developing “AirSENCE,” a novel technology for monitoring air quality. Their work is now going public in a high-profile